Kotaro Nochioka

Nov 14, 2024 | onlinelibrary.wiley.com | Kotaro Nochioka |Satoshi Yasuda |Takashi Shiroto |Saori Yamamoto

Background A personal health record (PHR) is an electronic repository of an individual's health information and a valuable tool for personal healthcare and disease management, which is controlled by the individual.1 In patients after myocardial infarction, compared with usual care, implementation of PHRs has resulted in successful outcomes, such as adherence to lifestyle advice and self-control of risk factors in addition to centre-based cardiac rehabilitation.2 However, comprehensive data on...

Apr 16, 2024 | onlinelibrary.wiley.com | Shinsuke Yamanaka |Kotaro Nochioka |Takashi Shiroto |Hideka Hayashi

Introduction Heart failure (HF) with preserved left ventricular (LV) ejection fraction (LVEF) (HFpEF) is a heterogeneous disorder, and various phenotyping approaches have been employed to enhance patient management.1 However, as HFpEF is generally considered a disease of the elderly,2, 3 there is a lack of information regarding younger HFpEF patients.

Mar 1, 2024 | onlinelibrary.wiley.com | Kanako Teramoto |Kotaro Nochioka |Aoba-ku Sendai Japan |Yasuhiko Sakata

Introduction Growth differentiation factor-15 (GDF15) is a member of the transforming growth factor beta superfamily known to be up-regulated in response to oxidative stress, tissue injury, and subsequent inflammation.1 Previous studies suggested robust associations between GDF15 and a variety of diseases, including heart failure (HF), cancer, cognitive decline, pulmonary diseases, diabetes, and renal disease.2-6 Its remarkable cardioprotective properties7 and prognostic significance in...

Sep 29, 2023 | onlinelibrary.wiley.com | Taijyu Satoh |Nobuhiro Yaoita |Kotaro Nochioka |Shunsuke Tatebe

Introduction The pathophysiology of pulmonary hypertension (PH) due to left-sided heart disease is distinct from that of other groups of PH.